Support The Moscow Times!

Namibia Halts Use of Russian Sputnik Jabs After S.African HIV Fears

Alexander Demianchuk / TASS

Namibia has discontinued the use of Russia's Sputnik V Covid-19 vaccine following concerns raised by neighboring South Africa, the health ministry said on Saturday.

Neighboring South Africa earlier this week said it would not approve Sputnik V due to concerns it could increase the risk of HIV infection among men, a claim the vaccine's developer says is unfounded.

The Namibian health ministry said in a statement that following South Africa's decision it was suspending, with immediate effect, use of the shots until the formula is listed for emergency use by the World Health Organization.

"The reason for discontinuation of the administration of the vaccine is being done out of abundance of caution that men who received Sputnik V may be at higher risk of contracting HIV when exposed to it," said the ministry.

Namibia had taken delivery of a Serbian donation of 30,000 Sputnik doses — out of which less than 120 have been administered so far.

South Africa's health products regulator on Monday said it would not authorize use of Sputnik based on earlier studies testing the safety of a modified form of adenovirus — a type of virus that causes respiratory infections — known as the Ad5 and contained in the jab.

The regulator said two previous studies, one in South Africa and one in the Americas, found a heightened risk of HIV infection among men linked to the Ad5-vectored vaccine.

In both trials, "administration of an Ad5-vectored vaccine was associated with enhanced susceptibility/acquisition of HIV in men," the regulator said last week.

Russia's Gamaleya Center, which developed Sputnik V, says any allegation of a link between the vaccine and HIV is unfounded.

It says clinical studies on more than 7,000 participants showed "there was no statistically significant increase of HIV-1 infection among adenovirus type-5 vectored vaccine recipients."

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysis and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more